Targovax ASA (GB:0RIS) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Circio Holding ASA has increased its share capital following the conversion of convertible bonds, positioning itself as a leader in circular RNA gene therapies. The company’s innovative circVec platform enhances protein expression, potentially setting a new standard for DNA and virus-based therapeutics. Additionally, Circio is advancing its cancer vaccine, TG01, in clinical trials across the USA and Norway, backed by significant research grants.
For further insights into GB:0RIS stock, check out TipRanks’ Stock Analysis page.
